Follow
Helen Giamarellou
Title
Cited by
Cited by
Year
Metallo-β-lactamases: a last frontier for β-lactams?
G Cornaglia, H Giamarellou, GM Rossolini
The Lancet infectious diseases 11 (5), 381-393, 2011
9212011
Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe
M Souli, I Galani, H Giamarellou
Eurosurveillance 13 (47), 2008
7242008
International consensus guidelines for the optimal use of the polymyxins: endorsed by the American college of clinical pharmacy (ACCP), European society of clinical …
BT Tsuji, JM Pogue, AP Zavascki, M Paul, GL Daikos, A Forrest, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (1 …, 2019
6872019
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram …
D Plachouras, M Karvanen, LE Friberg, E Papadomichelakis, ...
Antimicrobial agents and chemotherapy 53 (8), 3430-3436, 2009
6222009
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective …
B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ...
The Lancet Infectious Diseases 17 (7), 726-734, 2017
4772017
An Outbreak of Infection due to β-Lactamase Klebsiella pneumoniae Carbapenemase 2–Producing K. pneumoniae in a Greek University Hospital: Molecular …
M Souli, I Galani, A Antoniadou, E Papadomichelakis, G Poulakou, ...
Clinical infectious diseases 50 (3), 364-373, 2010
4362010
Multidrug-resistant Gram-negative infections: what are the treatment options?
H Giamarellou, G Poulakou
Drugs 69, 1879-1901, 2009
4222009
Acinetobacter baumannii: a universal threat to public health?
H Giamarellou, A Antoniadou, K Kanellakopoulou
International journal of antimicrobial agents 32 (2), 106-119, 2008
4192008
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial
LPG Derde, BS Cooper, H Goossens, S Malhotra-Kumar, RJL Willems, ...
The Lancet infectious diseases 14 (1), 31-39, 2014
4052014
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
I Karaiskos, H Giamarellou
Expert opinion on pharmacotherapy 15 (10), 1351-1370, 2014
3972014
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
Y Carmeli, M Akova, G Cornaglia, GL Daikos, J Garau, S Harbarth, ...
Clinical Microbiology and Infection 16 (2), 102-111, 2010
3632010
Health care–associated native valve endocarditis: importance of non-nosocomial acquisition
N Benito, JM Miro, E De Lazzari, CH Cabell, A Del Rio, J Altclas, ...
Annals of internal medicine 150 (9), 586-594, 2009
3322009
Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster
A Antoniadou, F Kontopidou, G Poulakou, E Koratzanis, I Galani, ...
Journal of Antimicrobial Chemotherapy 59 (4), 786-790, 2007
3222007
Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill
AF Mohamed, I Karaiskos, D Plachouras, M Karvanen, K Pontikis, ...
Antimicrobial agents and chemotherapy 56 (8), 4241-4249, 2012
3082012
Multidrug-resistant Gram-negative bacteria: how to treat and for how long
H Giamarellou
International journal of antimicrobial agents 36, S50-S54, 2010
2882010
Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing …
K Pontikis, I Karaiskos, S Bastani, G Dimopoulos, M Kalogirou, M Katsiari, ...
International journal of antimicrobial agents 43 (1), 52-59, 2014
2842014
Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance
A Bauernfeind, I Stemplinger, R Jungwirth, H Giamarellou
Antimicrobial agents and chemotherapy 40 (1), 221-224, 1996
2671996
Community-acquired methicillin-resistant Staphylococcus aureus infections
HC Maltezou, H Giamarellou
International journal of antimicrobial agents 27 (2), 87-96, 2006
2652006
Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?
EJ Giamarellos-Bourboulis, A Mega, P Grecka, N Scarpa, G Koratzanis, ...
Intensive care medicine 28, 1351-1356, 2002
2442002
Central nervous system manifestations of Mycoplasma pneumoniae infections
S Tsiodras, I Kelesidis, T Kelesidis, E Stamboulis, H Giamarellou
Journal of Infection 51 (5), 343-354, 2005
2422005
The system can't perform the operation now. Try again later.
Articles 1–20